LAS VEGAS — Onychomycosis, a stubborn fungal infection of the nail bed, is responsible for half of all nail diseases and presents a tricky challenge when it comes to both diagnosis and treatment. “The ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA), Wednesday announced that it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application for its VTR-297 ...

Asia Pacific, however, is emerging as the fastest-growing region due to urbanization, rising disposable incomes, and higher ...

Because of increasing antifungal resistance, an accurate diagnosis is important to provide appropriate treatment to patients with onychodystrophy. To identify factors associated with ...